WHO’s end of TB targets: unachievable by 2035 without addressing under nutrition, forced displacement, and homelessness: trend analysis from 2015 to 2022
BMC Public Health
4 April 2024 /open access/
**************
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
The Lancet Infectious Diseases
12 April 2024 /open access/
-- Accompanying comment: A new tool for accelerating tuberculosis vaccine development
/open access/
**************
Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: a diagnostic accuracy study
The Lancet Global Health
4 April 2024 /open access/
-- Accompanying comment: Thinking beyond diagnostic accuracy to evaluate tuberculosis screening tests
/open access/
**************
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study
The Lancet Global Health
4 April 2024 /open access/
-- Accompanying comment: Tuberculosis screening in adults with HIV: beyond symptoms
/open access/
**************